Saturday, June 13, 2026

Kim Jong Un Showcases North Korea’s Most Powerful Nuclear Missile Yet—The Hwasong-20

North Korea showcased its Hwasong-20 ICBM as a key nuclear asset during a military parade marking the Workers' Party's 80th anniversary.

The U.S. Is Moving Fast on Stablecoins—and South Korea May Be Running Out of Time

The U.S. is advancing stablecoin regulation with the Genius Act, while South Korea lags behind in legislative efforts, risking competitiveness.

Amazon’s AI Will Now Fill Your Screen With Ads When You Pause a Show

Amazon is innovating streaming ads with AI-driven pause ads that deliver tailored, context-aware advertisements to viewers.

Tag: ALT-B4

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Alteogen and Biogen: A Game-Changing 200 Million USD License Deal for ALT-B4 Biopharmaceuticals

Alteogen partners with Biogen for exclusive licensing of subcutaneous biopharmaceuticals, potentially earning up to 549 million USD.

Alteogen Secures U.S. Patent for Keytruda Subcutaneous Injection: What This Means for ALT-B4 and Future Treatments

Alteogen secures a U.S. patent for a subcutaneous Keytruda formulation using ALT-B4, ensuring exclusivity until 2043 and potential $1B in sales.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.